Platelet-rich Plasma (PRP) therapy uses injections of a concentration of a patient's own platelets to accelerate the healing of injured tendons, ligaments, muscles and joints. In this way, PRP injections use each individual patient's own healing system to improve musculoskeletal problems. PRP contains concentrated amounts of the patient’s own growth factors, cytokines, and proteins to promote the healing of damaged tissue.
Platelet-rich Fibrin Matrix (PRM) therapy uses whole blood from the patient to create a 3D autologous fibrin scaffolding (clot). This is a similar alternative to standard PRP, that provides the full compliments of plasma, leukocytes, cytokines, and growth factors that are in an activated fibrin matrix providing a unique structure and sustained release in an exogenous fibrin blood clot scaffold. This exogenous fibrin blood clot can act as a mechanism for short- and long-term delivery of growth factors and a 3D native scaffold for cell adhesion and proliferation.